Antifungal susceptibility ofCandidaspecies isolated from patients with candidemia in southern Taiwan, 2007-2012: impact of new antifungal breakpoints

Early initiation of appropriate treatment is associated with increased survival in cancer patients with Candida glabrata fungaemia: a potential benefit from infectious disease consultation

(2015) Dimitrios Farmakiotis et al.   CLINICAL MICROBIOLOGY AND INFECTION

Changing epidemiology of candidemia in a medical center in middle Taiwan

(2015) Ing-Moi Hii et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Antifungal Susceptibilities of Candida Isolates Causing Bloodstream Infections at a Medical Center in Taiwan, 2009-2010

(2014) Yu-Tsung Huang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Real-World Experience with Echinocandin MICs against Candida Species in a Multicenter Study of Hospitals That Routinely Perform Susceptibility Testing of Bloodstream Isolates

(2014) Gregory A. Eschenauer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemiology, species distribution and outcome of nosocomial Candida spp.bloodstream infection in Shanghai

(2014) Zhi-Tao Yang et al.   BMC INFECTIOUS DISEASES

Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance

(2014) Meng Xiao et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Use of Anidulafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 4,290 Clinical Isolates of Candida by Using CLSI Methods and Interpretive Criteria

(2014) Michael A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Impact of New Antifungal Breakpoints on Antifungal Resistance in Candida Species

(2014) A. W. Fothergill et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Candida tropicalis isolates obtained from veterinary sources show resistance to azoles and produce virulence factors

(2014) R. d. A. Cordeiro et al.   MEDICAL MYCOLOGY

Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?

(2013) A. Espinel-Ingroff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Caspofungin MICs Correlate with Treatment Outcomes among Patients with Candida glabrata Invasive Candidiasis and Prior Echinocandin Exposure

(2013) Ryan K. Shields et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China

(2013) Chun-fang Ma et al.   BMC INFECTIOUS DISEASES

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

(2013) Barbara D. Alexander et al.   CLINICAL INFECTIOUS DISEASES

Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme

(2013) M.C. Arendrup et al.   CLINICAL MICROBIOLOGY AND INFECTION

Epidemiology, Species Distribution, Antifungal Susceptibility, and Outcome of Candidemia across Five Sites in Italy and Spain

(2013) M. Bassetti et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Use of Micafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 3,764 Clinical Isolates of Candida by Use of CLSI Methods and Interpretive Criteria

(2013) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance

(2013) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia

(2013) Sai-Cheong Lee et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials

(2012) D. R. Andes et al.   CLINICAL INFECTIOUS DISEASES

Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values

(2012) M.A. Pfaller et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

The changing epidemiology of healthcare-associated candidemia over three decades

(2012) Daniel Diekema et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution

(2012) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012

(2012) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Comparison of the Vitek 2 Antifungal Susceptibility System with the Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Reference Methods and with the Sensititre YeastOne and Etest Techniques for In Vitro Detection of Antifungal Resistance in Yeast Isolates

(2010) M. Cuenca-Estrella et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

(2009) David L. Horn et al.   CLINICAL INFECTIOUS DISEASES

Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America

(2009) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Species distribution and antifungal susceptibility of blood Candida isolates at a tertiary hospital in southern Taiwan, 1999-2006

(2009) Po-Lin Chen et al.   MYCOSES

Clinical Evaluation of the Sensititre YeastOne Colorimetric Antifungal Panel for Antifungal Susceptibility Testing of the Echinocandins Anidulafungin, Caspofungin, and Micafungin

(2008) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY